RACHEL HIPPEARD: Open Payments
NPI 1548926348 · MECHANICSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 48 payments from 17 companies in 2025. Trend: 2023 $484 · 2024 $551 · 2025 $810
Food & beverage: $791Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $193 |
| Novo Nordisk Inc | 5 | $105 |
| PFIZER INC. | 5 | $98 |
| Lilly USA, LLC | 4 | $84 |
| Seqirus USA Inc | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: UBRELVY, QULIPTA, Fluad, JARDIANCE, NURTEC ODT, MOUNJARO, Wegovy, SHINGRIX.
Industry payments across VA — which companies pay providers there.
